Physeon, manufacturer of Veinplicity, is pleased to announce the appointment of Debra Leeves as Chief Executive Officer, effective 24 April 2017” Physeon (2017).
Physeon report “Debra comes to Physeon with nearly 25 years of experience in the medical technology and biotechnology industries, with companies such as Merck, GlaxoSmithKline, GE Medical Diagnostics and Wyeth Pharmaceuticals (now Pfizer). Debra brings with her an immense amount of knowledge and expertise in successful medical technology product launches throughout Europe, the United States and Asia Pacific.
ReTweet if useful… Physeon announces the appointment of Debra Leeves as Chief Executive Officer https://ctt.ec/fmJhC+ @ivteam #ivteam
Most recently, Debra served as Vice President, International Sales & Marketing for Rex Bionics PLC, a London-based publicly traded company. In this role, Debra developed the Sales, Marketing, Media and Customer Service strategies, as well as advised on global formulary submissions and reimbursement strategies.”Full News Item
Thank you to our partners for supporting IVTEAM